Restoration of p53 in tumors via gene therapy has long been seen as a way of sensitizing cancers to these traditional treatment modalities [22], and TP53 gene therapy has been most often envisioned in the context of a combination therapy involving chemotherapy and/or radiotherapy. Here, TP53 is linked to cancer.